White Paper

The EU Falsified Medicines Directive – Concerted Action To Secure The pharmaceutical supply Chain

Source: Domino North America

By Mark Eaves

In recent years the production of, and trade in, falsified medicines – both research based and generic – has grown to become a global illegal business. At the borders of the EU alone over 30 million counterfeit medicines have been seized during the last five years, and the statistics regarding medicines supplied online are equally disturbing: according to the European Alliance for Safe Medicines, 62% of medicines purchased online are fake or substandard.

These medicines increasingly threaten patients’ health, because counterfeiting is no longer largely associated with ‘lifestyle’ medicines such as Viagra. Today life-saving medicines such as those designed to treat cardiovascular disease are increasingly being counterfeited.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online